US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GREY MATTERS HEALTH INC

0.3329

+0.00130.39%

Volume:56.00K

Turnover:19.70K

Market Cap:1.80M

PE:-0.76

High:0.3540

Open:0.3540

Low:0.3329

Close:0.3317

52wk High:0.6400

52wk Low:0.2183

Shares:5.42M

Float Shares:5.42M

Volume Ratio:59.98

T/O Rate:1.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4400

ROE:-124.73%

ROA:-23.51%

PB:2.23

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

GREY MATTERS HEALTH INC

Exchange:

PINK LIMITED

Establishment Date:

2015

Employees:

- -

Office Location:

601 West Broadway,Suite 400,Vancouver,British Columbia,Canada

Website:

https://algernonpharmaceuticals.com/

Zip Code:

V5Z 4C2

Phone:

Fax:

- -

Introduction:

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/AGNPF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGNPF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNPF\",,,,,undefined,":{"symbol":"AGNPF","market":"US","secType":"STK","nameCN":"GREY MATTERS HEALTH INC","latestPrice":0.33294,"timestamp":1787601600000,"preClose":0.33166,"halted":0,"volume":56000,"delay":15,"changeRate":0.0038593740577700154,"floatShares":5418240,"shares":5418240,"eps":-0.44,"marketStatus":"Not Yet Opened","change":0.00128,"latestTime":"08-24 16:00:00 EDT Delay","open":0.354,"high":0.354,"low":0.33294,"amount":19697.94,"amplitude":0.063499,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.44,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.33166,"volumeRatio":59.982866},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNPF\",,,,,undefined,":{"symbol":"AGNPF","floatShares":5418240,"roa":"-23.51%","roe":"-124.73%","lyrEps":0,"volumeRatio":59.982866,"shares":5418240,"dividePrice":0,"high":0.354,"amplitude":0.063499,"preClose":0.33166,"low":0.33294,"week52Low":0.2183,"pbRate":"2.23","week52High":0.64,"institutionHeld":0,"latestPrice":0.33294,"eps":-0.44,"divideRate":0,"volume":56000,"delay":15,"ttmEps":-0.44,"open":0.354,"prevYearClose":0.05,"prevWeekClose":0.3317,"prevMonthClose":0.2485,"prevQuarterClose":0.3134,"fiveDayClose":0.3254,"twentyDayClose":0.2998,"sixtyDayClose":0.3211},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGNPF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-21","symbol":"AGNPF","defaultRemindTime":1776778200000,"type":"split","dateTimestamp":1776744000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2024-12-23","symbol":"AGNPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1734930000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-07-29","symbol":"AGNPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1722225600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-12-29","symbol":"AGNPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1703826000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-03-03","symbol":"AGNPF","defaultRemindTime":1677853800000,"type":"split","dateTimestamp":1677819600000,"forFactor":1,"toFactor":4,"ratio":0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGNPF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGNPF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":327047624,"yearFounded":2015,"address":"601 West Broadway,Suite 400,Vancouver,British Columbia,Canada","zipCode":"V5Z 4C2","officePhone":"604 398 4175","fiscalYearEnd":"08-31"},"stockCompanyDetail":{"websiteUrl":"https://algernonpharmaceuticals.com/","description":"Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.","exchange":"PINK LIMITED","name":"GREY MATTERS HEALTH INC","nameEN":"GREY MATTERS HEALTH INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AGNPF\",market:\"US\",,,undefined,":null}}